Valerie Wojna to Humans
This is a "connection" page, showing publications Valerie Wojna has written about Humans.
Connection Strength
0.538
-
Wojna V. Neuroinflammation and HIV-Associated Cognitive Impairment: Can They Be Eradicated? Neurology. 2022 09 20; 99(12):499-500.
Score: 0.042
-
Ram?rez-Marrero FA, P?rez-Frontera S, Amalbert-Birriel MA, Matos M, Santana-Bagur J, Frontera WR, Wojna V. Brief Report: Effects of Low-Volume High-Intensity Interval Training in Hispanic HIV+ Women: A Nonrandomized Study. J Acquir Immune Defic Syndr. 2020 07 01; 84(3):285-289.
Score: 0.037
-
Wojna V. ZIKA VIRUS - The Puerto Rican Experience. P R Health Sci J. 2018 12; 37(Spec Issue):S3-S4.
Score: 0.033
-
Oda R, Shiramizu B, Agsalda-Garcia M, Kettlewell J, Wojna V. In Vitro Blood-Brain Barrier Modeling adapted for Peripheral Blood Mononuclear Cell Transmigration from HIV-Positive Patients for Clinical Research on Therapeutic Drug Intervention. P R Health Sci J. 2018 09; 37(3):155-159.
Score: 0.032
-
Wojna V. The PRHSJ goes Green: What does it Mean? P R Health Sci J. 2015 Dec; 34(4):181.
Score: 0.027
-
Gerena Y, Men?ndez-Delmestre R, Skolasky RL, Hechavarria RM, P?rez S, Hilera C, Gonz?lez C, Nath A, Wojna V. Soluble insulin receptor as a source of insulin resistance and cognitive impairment in HIV-seropositive women. J Neurovirol. 2015 Apr; 21(2):113-9.
Score: 0.025
-
Agsalda-Garcia M, Shiramizu B, Melendez L, Plaud M, Liang CY, Wojna V. Different levels of HIV DNA copy numbers in cerebrospinal fluid cellular subsets. J Health Care Poor Underserved. 2013 Nov; 24(4 Suppl):8-16.
Score: 0.023
-
Assessment, diagnosis, and treatment of HIV-associated neurocognitive disorder: a consensus report of the mind exchange program. Clin Infect Dis. 2013 Apr; 56(7):1004-17.
Score: 0.022
-
Morales D, Acevedo SF, Skolasky RL, Hechavarria R, Santiago S, De La Torre T, Maldonado E, Wojna V. Translational spatial task and its relationship to HIV-associated neurocognitive disorders and apolipoprotein E in HIV-seropositive women. J Neurovirol. 2012 Dec; 18(6):488-502.
Score: 0.021
-
Gerena Y, Skolasky RL, Velez JM, Toro-Nieves D, Mayo R, Nath A, Wojna V. Soluble and cell-associated insulin receptor dysfunction correlates with severity of HAND in HIV-infected women. PLoS One. 2012; 7(5):e37358.
Score: 0.021
-
Oquendo-Jim?nez I, Mena R, Antoun MD, Wojna V. Linguistic adaptation of the clinical dementia rating scale for a Spanish-speaking population: a focus group approach. P R Health Sci J. 2010 Jun; 29(2):102-8.
Score: 0.018
-
Brown A, Shiramizu B, Nath A, Wojna V. Translational research in NeuroAIDS: a neuroimmune pharmacology-related course. J Neuroimmune Pharmacol. 2011 Mar; 6(1):80-8.
Score: 0.018
-
Hidalgo MB, Rodr?guez E, Wojna V. Atypical presentation of basilar artery thrombosis due to hypercoagulable state and incidental patent foramen ovale: a case report. Bol Asoc Med P R. 2010 Apr-Jun; 102(2):54-7.
Score: 0.018
-
Wojna V, Robles L, Skolasky RL, Mayo R, Selnes O, de la Torre T, Maldonado E, Nath A, Mel?ndez LM, Lasalde-Dominicci J. Associations of cigarette smoking with viral immune and cognitive function in human immunodeficiency virus-seropositive women. J Neurovirol. 2007 Dec; 13(6):561-8.
Score: 0.015
-
Wojna V, Skolasky RL, McArthur JC, Maldonado E, Hechavarria R, Mayo R, Selnes O, Ginebra T, de la Torre T, Garcia H, Kraiselburd E, Melendez-Guerrero LM, Zorrilla CD, Nath A. Spanish validation of the HIV dementia scale in women. AIDS Patient Care STDS. 2007 Dec; 21(12):930-41.
Score: 0.015
-
Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, Cherner M, Clifford DB, Cinque P, Epstein LG, Goodkin K, Gisslen M, Grant I, Heaton RK, Joseph J, Marder K, Marra CM, McArthur JC, Nunn M, Price RW, Pulliam L, Robertson KR, Sacktor N, Valcour V, Wojna VE. Updated research nosology for HIV-associated neurocognitive disorders. Neurology. 2007 Oct 30; 69(18):1789-99.
Score: 0.015
-
Wojna V, Nath A. Challenges to the diagnosis and management of HIV dementia. AIDS Read. 2006 Nov; 16(11):615-6, 621-4, 626, 629-32.
Score: 0.014
-
Wojna V, Skolasky RL, Hechavarr?a R, Mayo R, Selnes O, McArthur JC, Mel?ndez LM, Maldonado E, Zorrilla CD, Garc?a H, Kraiselburd E, Nath A. Prevalence of human immunodeficiency virus-associated cognitive impairment in a group of Hispanic women at risk for neurological impairment. J Neurovirol. 2006 Oct; 12(5):356-64.
Score: 0.014
-
Wojna V, Carlson KA, Luo X, Mayo R, Mel?ndez LM, Kraiselburd E, Gendelman HE. Proteomic fingerprinting of human immunodeficiency virus type 1-associated dementia from patient monocyte-derived macrophages: A case study. J Neurovirol. 2004; 10 Suppl 1:74-81.
Score: 0.012
-
Shikuma CM, Wojna V, De Gruttola V, Siriwardhana C, Souza SA, Rodriguez-Benitez RJ, Turner EH, Kallianpur K, Bolzenius J, Chow D, Matos M, Shiramizu B, Clements DM, Premeaux TA, Ndhlovu LC, Paul R. Impact of antiretroviral therapy intensification with C-C motif chemokine receptor 5 antagonist maraviroc on HIV-associated neurocognitive impairment. AIDS. 2023 11 01; 37(13):1987-1995.
Score: 0.011
-
Wojna V, Guerrero L, Guzm?n J, Cotto M. Effect of flumazenil on electroencephalographic patterns induced by midazolam. P R Health Sci J. 2000 Dec; 19(4):353-6.
Score: 0.009
-
Gonz?lez-Feliciano JA, Akamine P, Cap?-V?lez CM, Delgado-V?lez M, Dussupt V, Krebs SJ, Wojna V, Polonis VR, Baerga-Ortiz A, Lasalde-Dominicci JA. A recombinant gp145 Env glycoprotein from HIV-1 expressed in two different cell lines: Effects on glycosylation and antigenicity. PLoS One. 2020; 15(6):e0231679.
Score: 0.009
-
Cantres-Rosario YM, Acevedo-Mariani FM, P?rez-Laspiur J, Haskins WE, Plaud M, Cantres-Rosario YM, Skolasky R, M?ndez-Berm?dez I, Wojna V, Mel?ndez LM. Microwave & magnetic proteomics of macrophages from patients with HIV-associated cognitive impairment. PLoS One. 2017; 12(7):e0181779.
Score: 0.007
-
Jimenez-Torres GJ, Wojna V, Rosario E, Hechevarr?a R, Alem?n-Batista AM, Matos MR, Madan A, Skolasky RL, Acevedo SF. Assessing health-related resiliency in HIV+ Latin women: Preliminary psychometric findings. PLoS One. 2017; 12(7):e0181253.
Score: 0.007
-
Salinas JL, Major CG, Pastula DM, Dirlikov E, Styczynski A, Luciano CA, Wojna V, Sharp TM, Sejvar JJ, Rivera-Garcia B. Incidence and clinical characteristics of Guillain-Barr? syndrome before the introduction of Zika virus in Puerto Rico. J Neurol Sci. 2017 Jun 15; 377:102-106.
Score: 0.007
-
Colon K, Perez-Laspiur J, Quiles R, Rodriguez Y, Wojna V, Shaffer SA, Leszyk J, Skolasky RL, Melendez LM. Macrophage secretome from women with HIV-associated neurocognitive disorders. Proteomics Clin Appl. 2016 Feb; 10(2):136-43.
Score: 0.007
-
Victorson D, Cavazos JE, Holmes GL, Reder AT, Wojna V, Nowinski C, Miller D, Buono S, Mueller A, Moy C, Cella D. Validity of the Neurology Quality-of-Life (Neuro-QoL) measurement system in adult epilepsy. Epilepsy Behav. 2014 Feb; 31:77-84.
Score: 0.006
-
Bandaru VV, Mielke MM, Sacktor N, McArthur JC, Grant I, Letendre S, Chang L, Wojna V, Pardo C, Calabresi P, Munsaka S, Haughey NJ. A lipid storage-like disorder contributes to cognitive decline in HIV-infected subjects. Neurology. 2013 Oct 22; 81(17):1492-9.
Score: 0.006
-
Morales D, Hechavarria R, Wojna V, Acevedo SF. YWHAE/14-3-3e: a potential novel genetic risk factor and CSF biomarker for HIV neurocognitive impairment. J Neurovirol. 2013 Oct; 19(5):471-8.
Score: 0.006
-
Cantres-Rosario Y, Plaud-Valent?n M, Gerena Y, Skolasky RL, Wojna V, Mel?ndez LM. Cathepsin B and cystatin B in HIV-seropositive women are associated with infection and HIV-1-associated neurocognitive disorders. AIDS. 2013 Jan 28; 27(3):347-56.
Score: 0.005
-
Cella D, Lai JS, Nowinski CJ, Victorson D, Peterman A, Miller D, Bethoux F, Heinemann A, Rubin S, Cavazos JE, Reder AT, Sufit R, Simuni T, Holmes GL, Siderowf A, Wojna V, Bode R, McKinney N, Podrabsky T, Wortman K, Choi S, Gershon R, Rothrock N, Moy C. Neuro-QOL: brief measures of health-related quality of life for clinical research in neurology. Neurology. 2012 Jun 05; 78(23):1860-7.
Score: 0.005
-
Kraft-Terry S, Gerena Y, Wojna V, Plaud-Valentin M, Rodriguez Y, Ciborowski P, Mayo R, Skolasky R, Gendelman HE, Mel?ndez LM. Proteomic analyses of monocytes obtained from Hispanic women with HIV-associated dementia show depressed antioxidants. Proteomics Clin Appl. 2010 Sep; 4(8-9):706-14.
Score: 0.005
-
Vel?zquez I, Plaud M, Wojna V, Skolasky R, Laspiur JP, Mel?ndez LM. Antioxidant enzyme dysfunction in monocytes and CSF of Hispanic women with HIV-associated cognitive impairment. J Neuroimmunol. 2009 Jan 03; 206(1-2):106-11.
Score: 0.004
-
Laspiur JP, Anderson ER, Ciborowski P, Wojna V, Rozek W, Duan F, Mayo R, Rodr?guez E, Plaud-Valent?n M, Rodr?guez-Orengo J, Gendelman HE, Mel?ndez LM. CSF proteomic fingerprints for HIV-associated cognitive impairment. J Neuroimmunol. 2007 Dec; 192(1-2):157-70.
Score: 0.004
-
Rozek W, Ricardo-Dukelow M, Holloway S, Gendelman HE, Wojna V, Melendez LM, Ciborowski P. Cerebrospinal fluid proteomic profiling of HIV-1-infected patients with cognitive impairment. J Proteome Res. 2007 Nov; 6(11):4189-99.
Score: 0.004
-
Nieves DM, Plaud M, Wojna V, Skolasky R, Mel?ndez LM. Characterization of peripheral blood human immunodeficiency virus isolates from Hispanic women with cognitive impairment. J Neurovirol. 2007 Aug; 13(4):315-27.
Score: 0.004
-
Turchan J, Sacktor N, Wojna V, Conant K, Nath A. Neuroprotective therapy for HIV dementia. Curr HIV Res. 2003 Oct; 1(4):373-83.
Score: 0.003
-
Luo X, Carlson KA, Wojna V, Mayo R, Biskup TM, Stoner J, Anderson J, Gendelman HE, Mel?ndez LM. Macrophage proteomic fingerprinting predicts HIV-1-associated cognitive impairment. Neurology. 2003 Jun 24; 60(12):1931-7.
Score: 0.003
-
Nath A, Hauser KF, Wojna V, Booze RM, Maragos W, Prendergast M, Cass W, Turchan JT. Molecular basis for interactions of HIV and drugs of abuse. J Acquir Immune Defic Syndr. 2002 Oct 01; 31 Suppl 2:S62-9.
Score: 0.003